Using Drugs to Discriminate — Adverse Selection in the Insurance Marketplace
Authors:
- Benjamin D. SommersBSBenjamin D. Sommers
- 29 January 2015
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 372 (5) , 399-402
Abstract
Eliminating discrimination on the basis of preexisting conditions is one of the central features of the Affordable Care Act (ACA). Before the legislation was passed, insurers in the nongroup market regularly charged high premiums to people with chronic conditions or denied them coverage entirely. To address these problems, the ACA instituted age-adjusted community rating for premiums and mandated that plans insure all comers. In combination with premium subsidies and the Medicaid expansion, these policies have resulted in insurance coverage for an estimated 10 million previously uninsured people in 2014.1Keywords
This publication has 3 references indexed in Scilit:
- GINA, Genetic Discrimination, and Genomic MedicineNew England Journal of Medicine, 2015
- Health Reform and Changes in Health Insurance Coverage in 2014New England Journal of Medicine, 2014
- Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D ProgramAmerican Economic Review, 2011